21 May 2009
Is donor DNA incorporated into recipient lymphoid cells?
M Zagozda, J Tyszka, J Rutkowska, W OlszewskiAnn Transplant 2009; 14(1): 68-68 :: ID: 880449
Abstract
Background: Processing and incorporation of fragments of DNA and oligonucleotides by mammalian and bacterial cells is a continuing physiological process. It is strongly intensified in inflammation, cancer cells and after tissue and organ transplantation. The outcome of DNA transfer between mammalian cells remains not well understood. It has been suggested that the donor DNA may play a role in rejection or creating a partial tolerance. Aim: to study whether donor DNA may be identified in recipient's immune cells and if so, whether it is located in cytoplasm or penetrates into the nucleus.
Material/Methods: In sex-mismatched combination male rat DNA was injected i.v. into 10 female rats. Recipient blood (PBM), lymph node (LN) and spleen (SPL) mononuclear cells were examined 24 hr later for the presence of SRY gene characteristic for Y-chromosome. SRY was detected using polymerase chain reaction (PCR) method and real-time PCR. The PCR products were analyzed by electrophoresis in12.5% polyacrylamide gel (PAGE; Phast System, Amersham Pharmacia Biotech) and silver stained (Silver Staining Kit; Amersham Pharmacia Biotech).
Results: SRY gene was detected in female PBM, LN and SPL cell cytoplasm in 2 out of 10 rats. Moreover, it was detected in PBM nuclei in 4 out of 10 rats and in LN cell nuclei also in 4 out of 10 rats.
Conclusions: Detection of donor male DNA in nuclei isolated from female cells suggests its spontaneous transport into recipients' cells and their nuclei. The question remains open whether this finding may have any relevance to the rejection or tolerance process.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






